• Services
    • Overview
    • Autoantibody Biomarker Profiling
    • Oncology Drug Screening
    • Immunoprofiling
    • Vaccine Development
    • Custom Protein Arrays
  • Applications
        • Disease Area
          • Autoimmune Disease
          • Immuno-oncology
          • Neurological Disease
          • Infectious Disease
        • Application Area
          • Biomarker Discovery
          • Patient Stratification
          • Response & Adverse Event Prediction
          • Diagnostics & CDx Development
  • Technology
    • Overview
    • KREX Protein Folding Technology
    • ORVAR Autoantigen Discovery Platform
    • The Value of Autoantibodies
    • Bioinformatics for Autoantibodies
  • Resources
    • Videos
    • Publications
    • Product Information
    • White Papers & Case Studies
    • Protein List
    • FAQ
  • About
    • Company Overview
      • Patents
    • Meet Our Team
    • News & Events
  • Menu Menu
  • Join Our Team
  • Contact

News & Events

Keep up to date on Sengenics news and events

Press Releases

Sengenics Corporation Announces Fredrik Sundberg as New Vice President of Market and Business Development

March 14, 2023
Learn More →
Events

Webinar: B Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC

January 31, 2023 -12 PM EST
SelectScience
Learn More →
Press Releases

Sengenics Corporation Announces Yvonne Linney, PhD as New Board Director

January 9, 2023
Learn More →
Press Releases

Sengenics Broadens Its Systems Serology Tools to Enable the Detection of a Wider Range of Autoantibody Biomarkers

November 30, 2022
Learn More →
Events

British Society for Immunology Congress 2022. Visit us at booth #17.

December 5 – 8, 2022
ACC Liverpool, Liverpool, UK
Learn More →
Events

50th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology.

November 29 - December 2, 2022
Melbourne Convention & Exhibition Centre (MCEC), Melbourne, Australia
Learn More →
Press Releases

Sengenics Prepares for Next Phase Growth and Welcomes Bioscience Industry Leader as New CEO

September 7, 2022
Learn More →
Events

Sengenics will be exhibiting at the Neuroscience 2022. Visit us at booth #621.

November 12-16, 2022
San Diego Convention Center, San Diego, CA
Learn More →
Events

Sengenics will be exhibiting at the Frontiers in Cancer Science in Singapore. Get in touch to plan a meeting.

November 7 - 9, 2022
Nanyang Tech University, Singapore
Learn More →
  • 1
  • 2
  • 3
  • …
  • 5
  • ›
Loading...

  • Services
  • Applications
  • Technology
  • Resources
  • About

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics.

Copyright 2008 – 2022 Sengenics All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap

Design and development by RainCastle Communications.

This site uses cookies. By continuing to use this site, you accept our use of cookies. Learn more about our Privacy Statement and Cookie Policy here.

I Accept

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsHide notification only

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Download the White Paper

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation


Read the Review

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.